Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza vaccine immunogenicity after pediatric haematopoietic stem cell transplant
ACTRN12614000240640Phase 4Completed
- Sponsor
- Princess Margaret Hospital for Children
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of trivalent inactivated influenza vaccine in influenza (2 arms), sponsored by Princess Margaret Hospital for Children. Primary endpoint: Influenza-specific haemagglutinin inhibition antibody levels. Started May 2013; status: completed.
02
Drugs
trivalent inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12614000240640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000240640.